Company: OFIX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-061062
Chunk: 12

Company: Orthofix Medical Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 12
---
          |
| Lucas Vitale                                                         |            |  11,423 |     | -14 | *          |
| Geoffrey C. Gillespie                                                |            |  24,166 |     | -15 | *          |
| Catherine M. Burzik                                                  |            | 112,803 |     | -16 | *          |
| Kimberley A. Elting                                                  |            | 386,138 |     | -17 | *          |
| All current directors and executive officers as a group (15 persons) |            | 527,493 |     |     | 1.3%       |

* Represents less than one percent. (1) The address for each person or entity listed in the table is c/o Orthofix Medical Inc., 3451 Plano Parkway, Lewisville, TX 75056. (2) Reflects 29,718 shares issuable pursuant to deferred stock units that are vested or potentially issuable within 60 days of April 21, 2025, and 11,913 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of April 21, 2025. (3) Reflects 338 shares owned directly, 24,088 shares issuable pursuant to deferred stock units that are vested or potentially issuable within 60 days of April 21, 2025, and 11,913 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of April 21, 2025. (4) Reflects 6,383 shares owned directly, 25,315 shares issuable pursuant to deferred stock units that are vested or potentially issuable within 60 days of April 21, 2025, and 11,913 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of April 21, 2025.

<div align='center'>7</div>

(5)Reflects 6,012 shares owned directly, 44,790 shares issuable pursuant to deferred stock units that are vested or potentially issuable within 60 days of April 21, 2025, and 24,701 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of April 21, 2025.

(6)Reflects 41,045 shares owned directly, 29,506 shares issuable pursuant to deferred stock units that are vested